Cargando…
Identification of Novel Biomarker Candidates for the Immunohistochemical Diagnosis of Cholangiocellular Carcinoma
The aim of this study was the identification of novel biomarker candidates for the diagnosis of cholangiocellular carcinoma (CCC) and its immunohistochemical differentiation from benign liver and bile duct cells. CCC is a primary cancer that arises from the epithelial cells of bile ducts and is char...
Autores principales: | Padden, Juliet, Megger, Dominik A., Bracht, Thilo, Reis, Henning, Ahrens, Maike, Kohl, Michael, Eisenacher, Martin, Schlaak, Jörg F., Canbay, Ali E., Weber, Frank, Hoffmann, Andreas-Claudius, Kuhlmann, Katja, Meyer, Helmut E., Baba, Hideo A., Sitek, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188994/ https://www.ncbi.nlm.nih.gov/pubmed/25034945 http://dx.doi.org/10.1074/mcp.M113.034942 |
Ejemplares similares
-
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
por: Mölleken, Christian, et al.
Publicado: (2019) -
Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients
por: Bracht, Thilo, et al.
Publicado: (2016) -
Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC
por: Pott, Leona L, et al.
Publicado: (2017) -
Mitochondriome and Cholangiocellular Carcinoma
por: Bahitham, Wesam, et al.
Publicado: (2014) -
Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics
por: Großerueschkamp, Frederik, et al.
Publicado: (2017)